Published Guidance, NICE advice and quality standards
Showing 111 to 118 of 118
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Bimekizumab for treating axial spondyloarthritis | TA918 | ||
| Pegunigalsidase alfa for treating Fabry disease | TA915 | ||
| Bimekizumab for treating active psoriatic arthritis | TA916 | ||
| Urinary incontinence in neurological disease: assessment and management | CG148 | ||
| Ovarian cancer: recognition and initial management | CG122 | ||
| Suspected cancer: recognition and referral | NG12 | ||
| Suspected neurological conditions: recognition and referral | NG127 | ||
| Hearing loss in adults: assessment and management | NG98 |